Gynecologic malignancies account for 1.09 million new cancer cases worldwide and for about 12% of the tumors affecting females. Approximately 10% of all female cancer survivors are aged 40 years or younger. Since cancers affecting female genital organs are usually treated with radical surgery, chemotherapy or chemoradiotherapy – approaches that induce permanent reproductive function impairment – the development of strategies to preserve fertility is one of the most important goals in gynecologic oncology (Tomao et al., 2016).